Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Psychotherapie, Psychosomatik, Medizinische Psychologie|August 12, 2008
[Motivation for exercise of cancer patients--results of randomized-efficacy study]Jörn Rau, Johannes Teichmann, Franz Petermann
Psychotherapie, Psychosomatik, Medizinische Psychologie|September 11, 2007
[Motivation for exercise of cancer patients--a longitudinal study of the Transtheoretical Model (TTM)]Jörn Rau, Johannes Teichmann, Franz Petermann
Contemporary Clinical Trials|December 15, 2015
Enriching Cognitive Behavior Therapy with Emotion Regulation Training for Patients with Multiple Medically Unexplained Symptoms (ENCERT): Design and implementation of a multicenter, randomized, active-controlled trialMaria Kleinstäuber, Japhia Gottschalk, Matthias Berking, et al.
Trials|April 22, 2018
Treating prolonged grief disorder with prolonged grief-specific cognitive behavioral therapy: study protocol for a randomized controlled trialRita Rosner, Eline Rimane, Anna Vogel, et al.
Investigational New Drugs|September 6, 2013
Addition of vandetanib to pegylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A randomized phase I/II study of the AGO Study Group (AGO-OVAR 2.13)Philipp Harter, Jalid Sehouli, Rainer Kimmig, et al.
JAMA Psychiatry|November 13, 2024
Grief-Specific Cognitive Behavioral Therapy vs Present-Centered Therapy: A Randomized Clinical TrialRita Rosner, Jörn Rau, Anette Kersting, et al.
Parkinsonism & Related Disorders|July 31, 2012
Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-studyGünther Deuschl, Michael Schüpbach, Karina Knudsen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 18, 2014
Myths and facts about the EARLYSTIM studyW M Michael Schüpbach, Jörn Rau, Jean-Luc Houeto, et al.
Translational Oncology|June 5, 2013
Evaluation of potentially predictive markers for anti-angiogenic therapy with sunitinib in recurrent ovarian cancer patientsDirk O Bauerschlag, Felix Hilpert, Werner Meier, et al.
Gynecologic Oncology|May 9, 2012
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IVWerner Meier, Andreas du Bois, Jörn Rau, et al.
Pageof 2